Generic medicine
Artemether + Lumefantrine
Artemether + Lumefantrine
Data statusRegistration & price fields require source verification.
13brands/products
9companies
13with current prices
Pakistan brand index
13 resultsAvailable brands
| Brand | Manufacturer | Strength | Form | Pack | Reg. no. | Official price |
|---|---|---|---|---|---|---|
| Anti-Mal | Harrison Pharmaceuticals | 20 mg + 120 mg | Tablet | 1 x 16’s | 060372 | PKR 589.742024-07-01 |
| Arteblax-L | MEDICAIDS PAKISTAN PVT LTD | 20 mg + 120 mg | Tablet | 1 x 16's | 055714 | PKR 670.222026-07-27 |
| Artemate Plus | SAFE PHARMACEUTICAL (PVT) LTD | 40 mg + 240 mg | Tablet | 1 x 8's | 061791 | PKR 396.252024-07-01 |
| Artiminum DS | Genome Pharmaceuticals (Pvt.) Ltd, | 80 mg + 480 mg | Tablet | 1 x 4's | 069719 | PKR 438.792026-07-27 |
| Artiminum Forte | Genome Pharmaceuticals (Pvt.) Ltd, | 40 mg + 240 mg | Tablet | 1 x 8's | 059390 | PKR 526.552026-07-27 |
| ATM | Genome Pharmaceuticals (Pvt.) Ltd, | 40 mg + 240 mg | Dispersible tablet | 1 x 8's | 064004 | PKR 526.552026-07-27 |
| Bio-Lumefar | Bio-Labs(Pvt) Ltd | 40 mg + 240 mg | Tablet | 1 x 8'x | 056953 | PKR 522.242026-07-27 |
| Gamet | Glitz Pharma | 20 mg + 120 mg | Capsule | 1 x 16's | 056266 | PKR 574.802025-09-04 |
| Lumy-A DS | Remington Pharmaceutical Industries (Pvt) Ltd | 80 mg + 480 mg | Tablet | 1 x 4's | 069389 | PKR 436.072026-07-30 |
| Lumy-A DS | Remington Pharmaceutical Industries (Pvt) Ltd | 40 mg + 240 mg | Tablet | 1 x 8's | 069388 | PKR 523.282026-07-30 |
| Mala Extra | Werrick Pharmaceuticals | 30 mg + 180 mg | Tablet | 1 x 6's | 082051 | PKR 580.692025-08-18 |
| Mosether Forte | Genome Pharmaceuticals (Pvt.) Ltd, | 40 mg + 240 mg | Capsule | 1 x 8's | 060185 | PKR 526.552026-07-27 |
| Winterm | Winthrox Laboratories Pvt. Ltd | 80 mg + 480 mg | Tablet | 1 x 8's | 100494 | PKR 689.312026-07-30 |
Independent editorial layer
Medicine information
Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.